Has Eric Munzer, DO received payments from drug or device companies?

Yes. Drug and device makers reported $948 in general payments to Eric Munzer, DO across 33 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Eric Munzer, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Eric Munzer, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Eric Munzer, DO

Otolaryngology · New Windsor, NYNPI 1063533404

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for otolaryngology clinicians in NY, where the typical reported total is $1,040.

$948in general payments, 2019–2025

Across 33 payments — averaging $28.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intersect ENT, Inc.$225
GSK$161
Medtronic$146
Optinose US, Inc.$131
Sanofi$58
Hikma Pharmaceuticals USA$51
plus $176 from 5 others

$7,321in research payments, 2019–2025

Across 2 payments — averaging $3660.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AstraZeneca$7K

What the payments were for

Food & beverage$948100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intersect ENT, Inc.	5	$225
GSK	9	$161
Medtronic	2	$146
Optinose US, Inc.	7	$131
Sanofi	2	$58
Hikma Pharmaceuticals USA	1	$51
Aerin Medical Inc.	1	$48
Inspire Medical Systems, Inc.	2	$43
Regeneron Healthcare Solutions, Inc.	2	$39
Acclarent, Inc	1	$25
Stryker	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NOVAPAK$127

How this compares

$948 in reported general payments places this provider in the 45th percentile of 701 otolaryngology providers in New York.

See all otolaryngology providers in New York →

Medicare billing

Part B allowed, 2024

$252,271

Medicare patients

813

Services billed

2,127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ipratropium Bromide	112	$4,233
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	30	$3,661
Fluticasone Propionate	248	$3,169
Azelastine Hcl	147	$2,751
Budesonide	23	$2,721
Ofloxacin	41	$1,169
Fluocinolone Acetonide Oil	23	$1,110
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	74	$536
Cefdinir	31	$440
Mupirocin	66	$426
Famotidine	98	$414
Doxycycline Hyclate	42	$308
Methylprednisolone	37	$211

Paid to pharmacies, not to this prescriber.

Other otolaryngology in New Windsor

Robert KellmanSyracuse$2.5M
Roheen RaithathaNew York$830K
Nora PerkinsAlbany$300K
Moshe EphratNew Hyde Park$250K
Gavin SetzenAlbany$243K
Habibullah JamalRye Brook$179K
Albert JenFlushing$171K
Dennis KrausNew York$159K
Nitin BhatiaWhite Plains$120K
Sveta KarelskyRochester$101K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →